These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Clinical Outcome
3 results:

  • 1. Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.
    Eppenberger M; Zlobec I; Baumhoer D; Terracciano L; Lugli A
    BMC Cancer; 2010 Mar; 10():93. PubMed ID: 20222950
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The oncologic benefit of high ligation of the inferior mesenteric artery in the surgical treatment of rectal or sigmoid colon cancer.
    Chin CC; Yeh CY; Tang R; Changchien CR; Huang WS; Wang JY
    Int J Colorectal Dis; 2008 Aug; 23(8):783-8. PubMed ID: 18438677
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Reciprocal regulation of rhoa and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma.
    Bellovin DI; Simpson KJ; Danilov T; Maynard E; Rimm DL; Oettgen P; Mercurio AM
    Oncogene; 2006 Nov; 25(52):6959-67. PubMed ID: 16715134
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.